LOGIN
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
April 2013
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
The Effects of Tibolone in Older Postmenopausal Women
N Engl J Med. 2008 Aug 14;359(7):697-708Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
4538 post-menopausal women (age 60-85) with low bone mineral density were randomized to either receive a daily dose of Tibolone (1.25mg) or an identical placebo. The results indicated that the use of tibolone resulted in a reduced risk for developing vertebral and non-vertebral fractures, invasive breast cancer as well as colon cancer. However, it is important to note that tibolone did increase th...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.